Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Net Tangible Assets

As of the most recent data (June 2026), BLACR shows a net tangible assets of $150M. That compares with $190M in the prior-year period — down 25.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLACR's net tangible assets is now $150M (was $190M) — a 25.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is outperforming or lagging.

Tracking BLACR's net tangible assets over time shows whether Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 is scaling, shrinking, or reshaping that part of the business. The current reading is $150M That compares with $190M in the prior-year period — down 25.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $150M) with ownership activity and broader fundamentals.